Adiponectin promotes preadipocyte differentiation via the PPARγ pathway.

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Atherosclerosis improvement may involve adiponectin (APN), adipocyte differentiation, and peroxisome proliferator-activated receptor gamma (PPARγ).
• Inflammation in epicardial adipose tissue is a key factor in atherosclerosis.

Purpose of the Study:

• To investigate the role of adiponectin (APN) in adipocyte differentiation under inflammatory conditions.
• To elucidate the involvement of the peroxisome proliferator-activated receptor gamma (PPARγ) signaling pathway in APN's effects.

Main Methods:

• Stimulation of mature adipocytes with lipopolysaccharide (LPS) to mimic inflammation.
• Overexpression of adiponectin (APN) in 3T3-L1 preadipocytes using Ad-apM1.
• Assessment of preadipocyte differentiation, cell viability, inflammatory markers (MCP-1, IL-6, IL-8, TNF-α), and key protein/gene expression (PPARγ, C/EBPα, Pref-1) via MTT assay, Oil Red O staining, qPCR, and Western blotting.

Main Results:

• Adiponectin (APN) overexpression enhanced 3T3-L1 preadipocyte differentiation and cell viability.
• APN significantly reduced inflammatory markers (MCP-1, IL-6, IL-8, TNF-α) and modulated adipogenic/preadipogenic factors (PPARγ, C/EBPα, Pref-1).
• Inhibition of PPARγ activity attenuated the beneficial effects of APN, indicating pathway involvement.

Conclusions:

• Adiponectin (APN) promotes preadipocyte differentiation and exerts anti-inflammatory effects under LPS-induced inflammatory conditions.
• The mechanism involves the upregulation of peroxisome proliferator-activated receptor gamma (PPARγ) expression and activation of its signaling pathway.